Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 GBX | -.--% | +6.25% | -26.09% |
May. 23 | Aptamer Group Signs New Contracts with Multiple Top Ten Pharma Partners | CI |
May. 22 | Aptamer Group Teams Up with Timser for First-ever Cervical Cancer Blood Test | MT |
Sales 2022 | 4.04M 5.14M | Sales 2023 | 1.75M 2.23M | Capitalization | 4.66M 5.94M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.55M | Net income 2023 | -7M -8.92M | EV / Sales 2022 | 15.1 x |
Net cash position 2022 | 5.38M 6.86M | Net Debt 2023 | 844K 1.08M | EV / Sales 2023 | 3.14 x |
P/E ratio 2022 |
-29.6
x | P/E ratio 2023 |
-0.59
x | Employees | 37 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.48% |
Latest transcript on Aptamer Group plc
1 week | +6.25% | ||
1 month | +25.93% | ||
3 months | +17.24% | ||
6 months | -26.09% | ||
Current year | -26.09% |
Managers | Title | Age | Since |
---|---|---|---|
David Bunka
FOU | Founder | - | 07-12-31 |
Arron Tolley
FOU | Founder | 46 | 07-12-31 |
Andrew Rapson
DFI | Director of Finance/CFO | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Fielding
BRD | Director/Board Member | 59 | 23-08-20 |
Arron Tolley
FOU | Founder | 46 | 07-12-31 |
David Bunka
FOU | Founder | - | 07-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.85 | -.--% | 2,593,632 |
24-05-30 | 0.85 | +3.03% | 4,473,600 |
24-05-29 | 0.825 | +3.13% | 12,921,520 |
24-05-28 | 0.8 | -.--% | 8,726,653 |
24-05-24 | 0.8 | -.--% | 1,549,899 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.09% | 5.05M | |
-9.49% | 28.16B | |
+25.35% | 8.33B | |
+33.25% | 4.39B | |
-35.85% | 2.43B | |
-9.44% | 1.6B | |
-13.39% | 1.5B | |
-32.84% | 1.15B | |
+7.80% | 964M | |
-37.56% | 872M |
- Stock Market
- Equities
- APTA Stock